SCHEMBL23510387

SCHEMBL23510387

O=[N+]([O-])c1ccc(Cl)cc1-c1ccc(-n2c3ccccc3c3ccccc32)cc1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 2/20 0.42
▸ TSHR P16473 1/20 0.42
▸ MAPT P10636 4/20 0.41
▸ NPSR1 Q6W5P4 3/20 0.41
▸ LMNA P02545 2/20 0.41
▸ GAA P10253 2/20 0.41
▸ HSD11B1 P28845 1/20 0.39
▸ POLB P06746 2/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ ATM Q13315 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ PDE7A Q13946 3/20 0.38
▸ PDE7B Q9NP56 2/20 0.38
▸ MEN1 O00255 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ CTSB P07858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16671030 0.90 L3MBTL1 (0.42) MAPK1TSHRMAPTNPSR1LMNA
SCHEMBL16671215 0.90 L3MBTL1 (0.42) MAPK1TSHRMAPTNPSR1LMNA
SCHEMBL22173008 0.84 ALDH1A1 (0.57) MAPTLMNAL3MBTL1KDM4EATM
SCHEMBL19501151 0.81 L3MBTL1 (0.40) MAPK1TSHRMAPTNPSR1LMNA
SCHEMBL19725244 0.80 MAPK1 (0.42) MAPK1TSHRMAPTNPSR1LMNA
SCHEMBL25941799 0.79 ALDH1A1 (0.58) MAPK1TSHRMAPTNPSR1LMNA
SCHEMBL9261807 0.79 ALDH1A1 (0.61) MAPK1TSHRMAPTNPSR1LMNA
SCHEMBL26148648 0.78 L3MBTL1 (0.50) LMNAGAAL3MBTL1KDM4EATM
SCHEMBL17029040 0.77 HSD11B1 (0.38) MAPK1TSHRMAPTNPSR1LMNA
SCHEMBL25963736 0.76 ALDH1A1 (0.47) MAPTLMNAPOLBL3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210184132-A1 COMPOUND, COMPOSITION INCLUDING THE SAME, LIQUID COMPOSITION, AND ORGANIC ELECTROLUMINESCENT DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-06-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210184132-A1 COMPOUND, COMPOSITION INCLUDING THE SAME, LIQUID COMPOSITION, AND ORGANIC ELECTROLUMINESCENT DEVICE TERT, TELO2, POT1 MAPK1 2605/4885TSHR 3981/4885MAPT 1374/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback